.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Citi
Merck
Baxter
Cipla
Covington
Colorcon
Farmers Insurance
QuintilesIMS
Fish and Richardson

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050655

« Back to Dashboard

NDA 050655 describes NALLPEN IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the NALLPEN IN PLASTIC CONTAINER profile page.

The generic ingredient in NALLPEN IN PLASTIC CONTAINER is nafcillin sodium. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.

Summary for 050655

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 050655

Ingredient-typePenicillins

Medical Subject Heading (MeSH) Categories for 050655

Suppliers and Packaging for NDA: 050655

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NALLPEN IN PLASTIC CONTAINER nafcillin sodium INJECTABLE;INJECTION 050655 NDA Baxter Healthcare Corporation 0338-1017 0338-1017-41 50 mL in 1 BAG (0338-1017-41)
NALLPEN IN PLASTIC CONTAINER nafcillin sodium INJECTABLE;INJECTION 050655 NDA Baxter Healthcare Corporation 0338-1019 0338-1019-48 100 mL in 1 BAG (0338-1019-48)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 20MG BASE/ML
Approval Date:Oct 31, 1989TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE/100ML
Approval Date:Oct 31, 1989TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
AstraZeneca
Queensland Health
Citi
Moodys
US Army
Cantor Fitzgerald
Baxter
Chubb
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot